As the second-largest employment generator in the country, the textile sector’s contribution to the economy is crucial, with MSMEs forming ...

Despite challenges like fluctuating gold prices and evolving consumer tastes, experts highlight opportunities in design-led, innovative pra...

The government’s temporary import duty relief may ease pressure on mills and exporters, but industry experts say deeper problems in product...

Indian MSMEs are urging a policy overhaul to boost global competitiveness, citing challenges from geopolitical shifts and supply chain disr...

India is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...

Kazakh President Tokayev's Brussels visit underscored the vital role of the Middle Corridor, a key Asia-Europe trade route, aligning with t...

Indian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...

Niti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...

India's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...

Government's Minimum Import Price (MIP) initiative to boost domestic drug makers faces a slow start. Despite setting price thresholds for k...

Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...

At the onset of the Iran war, eight urea, four diammonium phosphate (DAP), one ammonia and three sulphur vessels bound for India were stran...

The government will decide on extending import duty exemptions for 40 products after June 30. This decision hinges on the evolving situatio...

Consumers in India will not experience immediate price drops for daily essentials and home appliances. Manufacturers are holding onto raw m...

Prices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...

India's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...

India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...